Purple Biotech
@_PurpleBiotech
Purple Biotech (NASDAQ/TASE: PPBT) is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion & drug resistance
You might like
$PPBT Purple Biotech Achieves Toxicology Milestone Demonstrating an Expanded Therapeutic Window for CAPTN-3 Platform Tri-specific Antibody, IM1240 Read the full press release here: globenewswire.com/news-release/2…
$PPBT Purple Biotech Reports Positive New Preclinical Data Demonstrating Multi-Arm Anti-Tumor Activity Across Two CAPTN-3 Tri-Specific Antibodies at ESMO Immuno-Oncology Congress 2025 Read the full press release here: globenewswire.com/news-release/2…
$PPBT Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress Read the full press release here: globenewswire.com/news-release/2…
We are thrilled to announce the initiation of the Phase 2 study for CM24 as a potential 2L treatment for patients with #PDAC, expanding the potential for treatment for #patients while extending our cash runway through 2024. More: tinyurl.com/522f8ccs #oncology #cancer #PDAC
We are pleased to share interim safety & efficacy in our Phase 1b Study of CM24 in Combination w/ Opdivo at #AACR22 saw 1 confirmed PR & 3 SD in patients with advanced pancreatic cancer and PTC. 9 patients still in study follow-up #oncology #Cancer bit.ly/3KxZjce
We are pleased to issue the following letter from its Chief Executive Officer, Isaac Israel, to its shareholders: bit.ly/3guxNz4 #cancerresearch #curecancer #oncology
Purple is excited to announce that NT219 was well-tolerated in initial clinical data from our ongoing Phase 1/2 study with a partial response observed in a patient with refractory GE junction cancer #CancerResearch #ASCO21 #Curecancer bit.ly/34OKvCQ
Purple Biotech to present interim data from our ongoing Phase 1/2 clinical trial of NT219, a monotherapy for the treatment of solid tumors that has the potential to help people living with hard-to-treat cancers, on June 4 #ASCO21 #cancer #cancerresearch #oncologyresearch
Happy to present new data supporting NT219's MOA, a dual inhibitor, novel SM targeting IRS1/2 & STAT3 at the Epigenetics and Metabolism AACR Virtual Conference by researchers at TASMC & Tel-Aviv University #cancer #tasmc finance.yahoo.com/news/mechanism…
Proud to present the anti-tumor activity of NT219 in pembrolizumab-resistant head and neck cancer PDX models at AACR 2020 virtual meeting II #Cancer #AACR2020 #keytdura #oncology #headandneckcancer
Presenting phase 1 data on CM-24 in patients with advanced cancer at ASCO 2020 Virtual Meeting #ASCO20 #CEACAM1 #oncology #Immunotherapy
We are glad to announce U.S. FDA IND acceptance to conduct a phase 1/2 clinical trial of NT-219 for treatment of recurrent or metastatic solid tumors and head and neck cancer. tiny.cc/sfnjpz #cancer #headandneckcancer #solidtumors #clinicaltrials
Proud to announce the U.S. commercial launch of Consensi™, designed for the simultaneous treatment of hypertension and osteoarthritis pain. Consensi™ is being sold by Burke Therapeutics, the marketing partner of our distributor, Coeptis Pharmaceuticals. tiny.cc/qjbhpz
Proud to present today our expanded planned NT-219 clinical program for difficult to treat cancers, at the 2020 Multidisciplinary Head and Neck Cancers Symposium, being held in Scottsdale, Arizona #cancer #headandneckcancer #HNCS20
Most relapses of #cancer are attributed to #drugresistance. We are developing #oncology therapies to overcome tumor drug resistance, enhance treatment response and slow tumor progression. Learn more about our pipeline: bit.ly/2LkcnW2
United States Trends
- 1. Good Monday N/A
- 2. Yoko Taro N/A
- 3. Kash N/A
- 4. Tourette N/A
- 5. #MondayVibes N/A
- 6. #MondayMotivation N/A
- 7. #sieresshowseramcm N/A
- 8. #ราคีGALA N/A
- 9. Fear God N/A
- 10. Evangelion N/A
- 11. DataHaven Testnet N/A
- 12. SAROCHA X THE STAIN GALA N/A
- 13. 960 SAT N/A
- 14. #Blizzard2026 N/A
- 15. $NVO N/A
- 16. John Davidson N/A
- 17. State of the Union N/A
- 18. BAFTA N/A
- 19. Luci4 N/A
- 20. NieR N/A
You might like
-
London Stansted Airport
@STN_Airport -
StocksToTrade
@StocksToTrade -
buysellshort.net
@buysellshort -
Mitch Picks
@Mitch___Picks -
EagleNXT
@EagleNXT -
Zai Lab
@ZaiLab_Global -
Kartoon Studios
@KartoonStudios -
SimbaTrading
@simbatrading -
Radio Silent
@RadioSilentplay -
Gossamer Bio
@GossamerBio -
Passage Bio
@Passage_Bio -
lizard
@LizardX -
Tarsus Pharmaceuticals, Inc.
@TarsusRx -
Doctor DD™
@TheOnlyRampart1
Something went wrong.
Something went wrong.